0 Yorumlar
0 hisse senetleri
149 Views
0 önizleme
Site içinde arama yapın
Yeni insanlarla keşfedin, yeni bağlantılar oluşturmak ve yeni arkadaşlar edinmek
-
Please log in to like, share and comment!
-
Is RNA Therapeutics Leading the Next Wave of Biopharmaceutical Innovation?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value This global RNA Therapeutics Market research report carries out the methodical and comprehensive market research study that puts forth the facts and figures linked with any subject about RNA Therapeutics Market The forecast, analysis, evaluations, and estimations carried out in this RNA...0 Yorumlar 0 hisse senetleri 106 Views 0 önizleme
-
Is the Global RNA Therapeutics Market Driving the Next Wave of Biopharmaceutical Innovation?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine This global RNA Therapeutics Market...0 Yorumlar 0 hisse senetleri 220 Views 0 önizleme
-
South Korea Biologic Therapy Market Forecast: Toward Global Leadership in Biopharmaceutical InnovationThe South Korea Biologic Therapy Market forecast indicates exponential growth through 2035, driven by expanding R&D investment, digital healthcare adoption, and robust export demand. Future Market Outlook Forecasts suggest a strong CAGR through the next decade as biologics surpass traditional small-molecule drugs in both value and volume. Government-backed initiatives target biosimilar...0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme
-
Herpes Simplex Virus (HSV) Vaccines Market Reaching USD 1,360 Million by 2034According to a new report from Intel Market Research, the global Herpes Simplex Virus (HSV) Vaccines market was valued at USD 865 million in 2024 and is projected to reach USD 1,360 million by 2034, growing at a robust CAGR of 6.8% during the forecast period (2025–2034). This growth is driven by the increasing global prevalence of HSV infections, rising awareness about sexually...0 Yorumlar 0 hisse senetleri 83 Views 0 önizleme